Editor: NOEL GONZÁLEZ GOTERA Número 152 Diseño: Lic. Roberto Chávez y Liuder Machado. Semana 060914 – 120914 Foto: Lic. Belkis Romeu e Instituto Finlay La Habana, Cuba.
ARTÍCULOS CIENTÍFICOS
Publicaciones incluidas en PubMED durante el período comprendido entre el 6 y el 12 de septiembre de 2014. Con “vaccin*” en título: 92 artículos recuperados.
Vacunas meningococo (Neisseria meningitidis)
72. Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria.
Ferrari MJ, Fermon F, Nackers F, Llosa A, Magone C, Grais RF.
Int Health. 2014 Sep 5. pii: ihu062. [Epub ahead of print]
PMID: 25193978 [PubMed - as supplied by publisher]
Related citations
Select item 25193634
Vacunas neumococo (Streptococcus pneumoniae)
41. [The case of three infants in whom Streptococcus pneumoniae was isolated from their blood after inoculation with 7-valent pneumococcal conjugate vaccine--importance of the investigation of Streptococcus pneumoniae serotype].
Matsuhashi K, Arai M, Fujii T, Abe Y, Itabashi K.
Kansenshogaku Zasshi. 2014 Jul;88(4):478-9. Japanese. No abstract available.
PMID: 25199384 [PubMed - in process]
Related citations
Select item 25199340 1
58. Recent Approaches in Vaccine Development against Streptococcus pneumoniae.
Tarahomjoo S.
J Mol Microbiol Biotechnol. 2014 Aug 30;24(4):215-227. [Epub ahead of print]
PMID: 25196525 [PubMed - as supplied by publisher]
Related citations
Select item 25196483
82. 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D-Conjugate Vaccine: A Review in Infants and Children.
Plosker GL.
Paediatr Drugs. 2014 Sep 6. [Epub ahead of print]
PMID: 25192686 [PubMed - as supplied by publisher]
Related citations
Select item 25191902
85. Survey of the bp/tee genes from clinical Group A Streptococcus isolates in New Zealand - implications for vaccine development.
Steemson JD, Moreland NJ, Williamson D, Morgan J, Carter PE, Proft T.
J Med Microbiol. 2014 Sep 4. pii: jmm.0.080804-0. doi: 10.1099/jmm.0.080804-0. [Epub ahead of print]
PMID: 25190737 [PubMed - as supplied by publisher]
Related citations
Select item 25190531
91. Cost-effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK.
Jiang Y, Gauthier A, Keeping S, Carroll S.
Expert Rev Pharmacoecon Outcomes Res. 2014 Sep 5:1-15. [Epub ahead of print]
PMID: 25189087 [PubMed - as supplied by publisher]
Related citations
Select item 25188934
Vacunas fiebre tifoidea (Salmonella typhi) 2
33. Passive protection against Salmonella enterica serovar Enteritidis infection from maternally derived antibodies of hens vaccinated with a ghost vaccine.
Si W, Yu S, Chen L, Wang X, Zhang W, Liu S, Li G.
Res Vet Sci. 2014 Aug 8. pii: S0034-5288(14)00227-6. doi: 10.1016/j.rvsc.2014.08.001. [Epub ahead of print]
PMID: 25200368 [PubMed - as supplied by publisher]
Related citations
Select item 25200366
Vacuna tosferina (Bordetella pertussis)
43. Caspase-1-Independent Interleukin-1β Is Required for Clearance of Bordetella pertussis Infections and Whole-Cell Vaccine-Mediated Immunity.
Place DE, Muse SJ, Kirimanjeswara GS, Harvill ET.
PLoS One. 2014 Sep 8;9(9):e107188. doi: 10.1371/journal.pone.0107188. eCollection 2014.
PMID: 25198773 [PubMed - in process] Free Article
Related citations
Select item 25198681
Vacunas, otras
1. National Human Papillomavirus Vaccination Coverage Among Adolescents Aged 13- -17 Years --- National Immunization Survey -- Teen, United States, 2011.
Curtis CR, Dorell C, Yankey D, Jeyarajah J, Chesson H, Saraiya M, Gold R, Dunne EF, Stokley S.
MMWR Surveill Summ. 2014 Sep 12;63:61-70.
PMID: 25208260 [PubMed - as supplied by publisher]
Related citations
Select item 25207973 2.
Potential Future Impact of a Partially Effective HIV Vaccine in a Southern African Setting.
3
Phillips AN, Cambiano V, Nakagawa F, Ford D, Lundgren JD, Roset-Bahmanyar E, Roman F, Van Effelterre T.
PLoS One. 2014 Sep 10;9(9):e107214. doi: 10.1371/journal.pone.0107214. eCollection 2014.
PMID: 25207973 [PubMed - as supplied by publisher]
Related citations
Select item 25207509 3.
Support for HPV Vaccination Mandates for Both Females and Males.
Smith ML, Wilson KL, Pulczinski JC, Ory MG.
Am J Health Behav. 2014 Nov;38(6):831-838.
PMID: 25207509 [PubMed - as supplied by publisher]
Related citations
Select item 25207465 4.
In Situ Modulation of Dendritic Cells by Injectable Thermo-sensitive Hydrogels for Cancer Vaccines in Mice.
Liu Y, Xiao L, Joo KI, Hu B, Fang J, Wang P.
Biomacromolecules. 2014 Sep 10. [Epub ahead of print]
PMID: 25207465 [PubMed - as supplied by publisher]
Related citations
Select item 25207131 5.
Sudden hearing loss after rabies vaccination.
Güçlü O, Dereköy FS.
Balkan Med J. 2013 Sep;30(3):327-8. doi: 10.5152/balkanmedj.2013.8465. Epub 2013 Sep 1.
PMID:
4
25207131 [PubMed]
Related citations
Select item 25206960 6.
Different immunogenicity but similar antitumor efficacy of two DNA vaccines coding for an antigen secreted in different membrane vesicle-associated forms.
Sedlik C, Vigneron J, Torrieri-Dramard L, Pitoiset F, Denizeau J, Chesneau C, de la Rochere P, Lantz O, Thery C, Bellier B.
J Extracell Vesicles. 2014 Aug 27;3. doi: 10.3402/jev.v3.24646. eCollection 2014.
PMID: 25206960 [PubMed]
Related citations
Select item 25206925 7.
The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10-16 years.
Nakalembe M, Banura C, Namujju PB, Mirembe FM.
Infect Agent Cancer. 2014 Sep 1;9:29. doi: 10.1186/1750-9378-9-29. eCollection 2014.
PMID: 25206925 [PubMed]
Related citations
Select item 25206569 8.
A new DNA vaccine fused with the C3d-p28 induces a Th2 immune response against amyloid-beta.
Guo W, Sha S, Jiang T, Xing X, Cao Y.
Neural Regen Res. 2013 Sep 25;8(27):2581-90. doi: 10.3969/j.issn.1673- 5374.2013.27.010.
PMID: 25206569 [PubMed]
5
Related citations
Select item 25206302 9.
Pregnant inflammatory bowel disease patients may require counselling regarding live vaccines in newborns.
Sekaran A, Borum ML.
World J Gastroenterol. 2014 Sep 7;20(33):11927-8. doi: 10.3748/wjg.v20.i33.11927.
PMID: 25206302 [PubMed - in process]
Related citations
Select item 25205445 10.
Characterisation of immune responses in healthy foals when a multivalent vaccine protocol was initiated at 90 or 180 days of age.
Davis EG, Bello NM, Bryan AJ, Hankins K, Wilkerson M.
Equine Vet J. 2014 Sep 9. doi: 10.1111/evj.12350. [Epub ahead of print]
PMID: 25205445 [PubMed - as supplied by publisher]
Related citations
Select item 25205199 11.
Avian pathogenic Escherichia coli ΔtonB mutants are safe and protective live- attenuated vaccine candidates.
Holden KM, Browning GF, Noormohammadi AH, Markham P, Marenda MS.
Vet Microbiol. 2014 Aug 15. pii: S0378-1135(14)00370-8. doi: 10.1016/j.vetmic.2014.07.028. [Epub ahead of print]
PMID: 25205199 [PubMed - as supplied by publisher]
Related citations
Select item 25204909 12.
6
School nurses prepare for childhood flu vaccine pilot.
[No authors listed]
Nurs Stand. 2014 Sep 10;29(2):10. doi: 10.7748/ns.29.2.10.s9.
PMID: 25204909 [PubMed - in process]
Related citations
Select item 25204499 13.
A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses.
Boonsathorn N, Panthong S, Koksunan S, Chittaganpitch M, Phuygun S, Waicharoen S, Prachasupap A, Sasaki T, Kubota-Koketsu R, Yasugi M, Ono KI, Arai Y, Kurosu T, Sawanpanyalert P, Ikuta K, Watanabe Y.
Biochem Biophys Res Commun. 2014 Sep 6. pii: S0006-291X(14)01616-7. doi: 10.1016/j.bbrc.2014.09.008. [Epub ahead of print]
PMID: 25204499 [PubMed - as supplied by publisher]
Related citations
Select item 25204275 14.
[Testing of vaccines : The challenge of testing complex combination vaccines.]
Merkle A, Lechner H, Oppling V, Meyer H.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Sep 10. [Epub ahead of print] German.
PMID: 25204275 [PubMed - as supplied by publisher]
Related citations
Select item 25204147 15.
[Chemical constituents from Vaccinium bracteatum].
Qu J, Chen X, Niu CS, Yu SS.
7
Zhongguo Zhong Yao Za Zhi. 2014 Feb;39(4):684-8. Chinese.
PMID: 25204147 [PubMed - in process]
Related citations
Select item 25204041 16.
Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
Salama II, Sami SM, Salama SI, Foud WA, Abdel Hamid AT, Said ZN.
Egypt J Immunol. 2014;21(1):13-26.
PMID: 25204041 [PubMed - in process]
Related citations
Select item 25198660 17.
Epigenetically Modified Pancreatic Carcinoma PANC-1 Cells Can Act as Cancer Vaccine to Enhance Antitumor Immune Response in Mice.
Tao Y, Lin F, Li T, Xie J, Shen C, Zhu Z.
Oncol Res. 2013;21(6):307-16. doi: 10.3727/096504014X13983417587320.
PMID: 25198660 [PubMed - in process]
Related citations
Select item 25203744 18.
Human Papillomavirus Vaccination Awareness and Acceptability Among United States- Born and U.S. Foreign-Born Women Living in California.
Barnack-Tavlaris JL, Garcini LM, Macera CA, Brodine S, Klonoff EA.
Health Care Women Int. 2014 Sep 9:0. [Epub ahead of print]
PMID: 25203744 [PubMed - as supplied by publisher]
8
Related citations
Select item 25203449 19.
High need for MMR vaccination in HIV infected adults in Austria.
Grabmeier-Pfistershammer K, Poeppl W, Herkner H, Touzeau-Römer V, Huschka E, Rieger A, Burgmann H.
Vaccine. 2014 Sep 5. pii: S0264-410X(14)01200-6. doi: 10.1016/j.vaccine.2014.07.114. [Epub ahead of print]
PMID: 25203449 [PubMed - as supplied by publisher]
Related citations
Select item 25203448 20.
The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors.
O'Gorman WE, Huang H, Wei YL, Davis KL, Leipold MD, Bendall SC, Kidd BA, Dekker CL, Maecker HT, Chien YH, Davis MM.
Vaccine. 2014 Sep 5. pii: S0264-410X(14)01201-8. doi: 10.1016/j.vaccine.2014.07.115. [Epub ahead of print]
PMID: 25203448 [PubMed - as supplied by publisher]
Related citations
Select item 25203447 21.
VHSV G glycoprotein major determinants implicated in triggering the host type I IFN antiviral response as DNA vaccine molecular adjuvants.
Martinez-Lopez A, Garcia-Valtanen P, Ortega-Villaizan M, Chico V, Casado E, Coll JM, Estepa A.
Vaccine. 2014 Sep 5. pii: S0264-410X(14)01196-7. doi: 10.1016/j.vaccine.2014.07.111. [Epub ahead of print]
PMID: 25203447 [PubMed - as supplied by publisher]
Related citations
9
Select item 25203219 22.
Plant expression systems for production of hemagglutinin as a vaccine against influenza virus.
Redkiewicz P, Sirko A, Kamel KA, Góra-Sochacka A.
Acta Biochim Pol. 2014 Sep 9. [Epub ahead of print]
PMID: 25203219 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 25203218 23.
A universal flu vaccine.
Kesik-Brodacka M, Plucienniczak G.
Acta Biochim Pol. 2014 Sep 9. [Epub ahead of print]
PMID: 25203218 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 25203195 24.
Survey on Influenza Vaccination Noncompliance among Nursing Students.
Kang J, Engberg SJ, Muto CA.
Infect Control Hosp Epidemiol. 2014 Oct;35(10):1316-7. doi: 10.1086/678076. No abstract available.
PMID: 25203195 [PubMed - in process]
Related citations
Select item 25203053 25.
Parents' Knowledge, Risk Perception and Willingness to Allow Young Males to Receive Human Papillomavirus (HPV) Vaccines in Uganda.
10
Muhwezi WW, Banura C, Turiho AK, Mirembe F.
PLoS One. 2014 Sep 9;9(9):e106686. doi: 10.1371/journal.pone.0106686. eCollection 2014.
PMID: 25203053 [PubMed - in process] Free Article
Related citations
Select item 25202307 26.
Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches.
Joshi S, Rawat K, Yadav NK, Kumar V, Siddiqi MI, Dube A.
Front Immunol. 2014 Aug 22;5:380. doi: 10.3389/fimmu.2014.00380. eCollection 2014. Review.
PMID: 25202307 [PubMed] Free Article
Related citations
Select item 25202303 27.
The influence of delivery vectors on HIV vaccine efficacy.
Ondondo BO.
Front Microbiol. 2014 Aug 22;5:439. doi: 10.3389/fmicb.2014.00439. eCollection 2014. Review.
PMID: 25202303 [PubMed] Free Article
Related citations
Select item 25201636 28.
DNA vaccination with a gene encoding Toxoplasma gondii Deoxyribose Phosphate Aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice.
Hassan IA, Wang S, Xu L, Yan R, Song X, Li X.
11
Parasit Vectors. 2014 Sep 8;7(1):431. [Epub ahead of print]
PMID: 25201636 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 25201571 29.
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Teo E, House H, Lockhart K, Purchuri SN, Pushparajah J, Cripps AW, van Driel ML.
Cochrane Database Syst Rev. 2014 Sep 9;9:CD010010. [Epub ahead of print]
PMID: 25201571 [PubMed - as supplied by publisher]
Related citations
Select item 25201075 30.
Comparative Subproteome Analysis of Three Representative Leptospira Interrogans Vaccine Strains Reveals Cross-reactive Antigens and Novel Virulence Determinants.
Zeng LB, Zhuang XR, Huang LL, Zhang YY, Chen CY, Dong K, Zhang Y, Cui ZL, Ding XL, Chang YF, Guo XK, Zhu YZ.
J Proteomics. 2014 Sep 5. pii: S1874-3919(14)00413-8. doi: 10.1016/j.jprot.2014.08.015. [Epub ahead of print]
PMID: 25201075 [PubMed - as supplied by publisher]
Related citations
Select item 25200611 31.
Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation.
Mittal A, Schulze K, Ebensen T, Weißmann S, Hansen S, Lehr CM, Guzman CA.
Nanomedicine. 2014 Sep 5. pii: S1549-9634(14)00432-8. doi: 10.1016/j.nano.2014.08.009. [Epub ahead of print]
12
PMID: 25200611 [PubMed - as supplied by publisher]
Related citations
Select item 25200458 32.
Knowledge, attitudes and practices on adolescent vaccination among parents, teachers and adolescents in Africa: a systematic review protocol.
Abdullahi LH, Kagina BM, Cassidy T, Adebayo EF, Wiysonge CS, Hussey GD.
Syst Rev. 2014 Sep 9;3(1):100. [Epub ahead of print]
PMID: 25200458 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 25200368 33.
Passive protection against Salmonella enterica serovar Enteritidis infection from maternally derived antibodies of hens vaccinated with a ghost vaccine.
Si W, Yu S, Chen L, Wang X, Zhang W, Liu S, Li G.
Res Vet Sci. 2014 Aug 8. pii: S0034-5288(14)00227-6. doi: 10.1016/j.rvsc.2014.08.001. [Epub ahead of print]
PMID: 25200368 [PubMed - as supplied by publisher]
Related citations
Select item 25200366 34.
Parents' Choices and Rationales for Alternative Vaccination Schedules: A Qualitative Study.
Saada A, Lieu TA, Morain SR, Zikmund-Fisher BJ, Wittenberg E.
Clin Pediatr (Phila). 2014 Sep 7. pii: 0009922814548838. [Epub ahead of print]
PMID: 25200366 [PubMed - as supplied by publisher]
13
Related citations
Select item 25200351 35.
Liver fluke vaccines in ruminants: strategies, progress and future opportunities.
Toet H, Piedrafita DM, Spithill TW.
Int J Parasitol. 2014 Sep 5. pii: S0020-7519(14)00197-0. doi: 10.1016/j.ijpara.2014.07.011. [Epub ahead of print] Review.
PMID: 25200351 [PubMed - as supplied by publisher]
Related citations
Select item 25200253 36.
Malaria vaccine candidate antigen targeting the pre erythrocytic stage of Plasmodium falciparum produced at high-level in plants.
Voepel N, Boes A, Edgue G, Beiss V, Kapelski S, Reimann A, Schillberg S, Pradel G, Fendel R, Scheuermayer M, Spiegel H, Fischer R.
Biotechnol J. 2014 Sep 9. doi: 10.1002/biot.201400350. [Epub ahead of print]
PMID: 25200253 [PubMed - as supplied by publisher]
Related citations
Select item 25200152 37.
[Mouse macrophage-derived chemokine as an adjuvant enhances the protective effect of P6 protein vaccine of nontypeable Haemophilus influenzae].
Han X, Wang C, Qiao H, Zhang Y, Chang Y, Zhang Y.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Sep;30(9):913-6. Chinese.
PMID: 25200152 [PubMed - in process]
Related citations
Select item 25199897 38.
14
Power and persuasion in the vaccine debates: an analysis of political efforts and outcomes in the United States, 1998-2012.
Lillvis DF, Kirkland A, Frick A.
Milbank Q. 2014 Sep;92(3):475-508. doi: 10.1111/1468-0009.12075.
PMID: 25199897 [PubMed - in process]
Related citations
Select item 25199887 39.
Global polio eradication: espionage, disinformation, and the politics of vaccination.
Gostin LO.
Milbank Q. 2014 Sep;92(3):413-7. doi: 10.1111/1468-0009.12065. No abstract available.
PMID: 25199887 [PubMed - in process]
Related citations
Select item 25199525 40.
Apoptosis and other immune biomarkers predict influenza vaccine responsiveness.
Furman D, Jojic V, Kidd B, Shen-Orr S, Price J, Jarrell J, Tse T, Huang H, Lund P, Maecker HT, Utz PJ, Dekker CL, Koller D, Davis MM.
Mol Syst Biol. 2014 Sep 8;10(9):750. doi: 10.15252/msb.20145632. No abstract available.
PMID: 25199525 [PubMed - in process] Free Article
Related citations
Select item 25199384 41.
[The case of three infants in whom Streptococcus pneumoniae was isolated from their blood after inoculation with 7-valent pneumococcal conjugate vaccine--importance of the investigation of Streptococcus pneumoniae serotype].
15
Matsuhashi K, Arai M, Fujii T, Abe Y, Itabashi K.
Kansenshogaku Zasshi. 2014 Jul;88(4):478-9. Japanese. No abstract available.
PMID: 25199384 [PubMed - in process]
Related citations
Select item 25199340 42.
[Influence of heavy metals on surfactants synthesis by Nocardia vaccinii IMV B-7405].
[No authors listed]
Mikrobiol Z. 2014 Jul-Aug;76(4):9-16. Russian.
PMID: 25199340 [PubMed - in process]
Related citations
Select item 25198773 43.
Caspase-1-Independent Interleukin-1β Is Required for Clearance of Bordetella pertussis Infections and Whole-Cell Vaccine-Mediated Immunity.
Place DE, Muse SJ, Kirimanjeswara GS, Harvill ET.
PLoS One. 2014 Sep 8;9(9):e107188. doi: 10.1371/journal.pone.0107188. eCollection 2014.
PMID: 25198773 [PubMed - in process] Free Article
Related citations
Select item 25198681 44.
A Dose-Response Relationship between Organic Mercury Exposure from Thimerosal- Containing Vaccines and Neurodevelopmental Disorders.
Geier DA, Hooker BS, Kern JK, King PG, Sykes LK, Geier MR.
Int J Environ Res Public Health. 2014 Sep 5;11(9):9156-70. doi: 10.3390/ijerph110909156.
16
PMID: 25198681 [PubMed - in process] Free Article
Related citations
Select item 25198614 45.
The impact of ten years of infant universal Varicella vaccination in Sicily, Italy (2003- 2012).
Amodio E, Tramuto F, Cracchiolo M, Sciuto V, De Donno A, Guido M, Rota MC, Gabutti G, Vitale F.
Hum Vaccin Immunother. 2014 Aug 27;11(1). [Epub ahead of print]
PMID: 25198614 [PubMed - as supplied by publisher]
Related citations
Select item 25198544 46.
Correction: 2012-2013 Seasonal Influenza Vaccine Effectiveness against Influenza Hospitalizations: Results from the Global Influenza Hospital Surveillance Network.
PLOS ONE Staff.
PLoS One. 2014 Sep 8;9(9):e107849. doi: 10.1371/journal.pone.0107849. eCollection 2014.
PMID: 25198544 [PubMed - in process] Free Article
Related citations
Select item 25198526 47.
Therapeutic Antitumor Efficacy of B Cells Loaded With Tumor-derived Autophagasomes Vaccine (DRibbles).
Ren H, Zhao S, Li W, Dong H, Zhou M, Cao M, Hu HM, Wang LX.
J Immunother. 2014 Oct;37(8):383-93. doi: 10.1097/CJI.0000000000000051.
PMID: 25198526 [PubMed - in process] 17
Related citations
Select item 25198357 48.
[Thimerosal in vaccines - white, black, or quite the opposite?].
Rada G.
Medwave. 2014 Mar 31;14(2). pii: e5929. doi: 10.5867/medwave.2014.02.5929. Spanish.
PMID: 25198357 [PubMed - in process]
Related citations
Select item 25198289 49.
Response to Booster Doses of Hepatitis B Vaccine among Young Adults Who Had Received Neonatal Vaccination.
Chan PK, Ngai KL, Lao TT, Wong MC, Cheung T, Yeung AC, Chan MC, Luk SW.
PLoS One. 2014 Sep 8;9(9):e107163. doi: 10.1371/journal.pone.0107163. eCollection 2014.
PMID: 25198289 [PubMed - in process] Free Article
Related citations
Select item 25198123 50.
Correction: intent to participate in future cervical cancer screenings is lower when satisfaction with the decision to be vaccinated is neutral.
PLOS ONE Staff.
PLoS One. 2014 Sep 8;9(9):e107790. doi: 10.1371/journal.pone.0107790. eCollection 2014.
PMID: 25198123 [PubMed - in process] Free Article
Related citations
18
Select item 25198104 51.
Costs and Cost-Effectiveness of 9-Valent Human Papillomavirus (HPV) Vaccination in Two East African Countries.
Kiatpongsan S, Kim JJ.
PLoS One. 2014 Sep 8;9(9):e106836. doi: 10.1371/journal.pone.0106836. eCollection 2014.
PMID: 25198104 [PubMed - in process] Free Article
Related citations
Select item 25198037 52.
Malaria vaccine, destined for Africa, seeks OK from Europe.
Willyard C.
Nat Med. 2014 Sep 4;20(9):968-9. doi: 10.1038/nm0914-968. No abstract available.
PMID: 25198037 [PubMed - in process]
Related citations
Select item 25197967 53.
Long-term immunogenicity studies of formalin-inactivated enterovirus 71 whole-virion vaccine in macaques.
Liu CC, Hwang CS, Yang WS, Tsai DC, Wu SH, Chou AH, Chow YH, Wu SC, Wang JR, Chiang JR, Huang CC, Pan CH, Chong P.
PLoS One. 2014 Sep 8;9(9):e106756. doi: 10.1371/journal.pone.0106756. eCollection 2014.
PMID: 25197967 [PubMed - in process] Free Article
Related citations
Select item 25197336 54.
19
Design of a ProDer f 1 vaccine delivered by the MHC class II pathway of antigen presentation and analysis of the effectiveness for specific immunotherapy.
Liu Z, Jiang Y, Li C.
Int J Clin Exp Pathol. 2014 Jul 15;7(8):4636-44. eCollection 2014.
PMID: 25197336 [PubMed - in process]
Related citations
Select item 25197078 55.
Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals.
Hu H, Eller MA, Zafar S, Zhou Y, Gu M, Wei Z, Currier JR, Marovich MA, Kibuuka HN, Bailer RT, Koup RA, Robb ML, Michael NL, Kim JH, Ratto-Kim S.
Proc Natl Acad Sci U S A. 2014 Sep 2. pii: 201400446. [Epub ahead of print]
PMID: 25197078 [PubMed - as supplied by publisher]
Related citations
Select item 25196949 56.
Thalidomide for the treatment of hydroa vacciniforme-like lymphoma: Report of four pediatric cases from Peru.
Beltrán BE, Maza I, Moisés-Alfaro CB, Vasquez L, Quiñones P, Morales D, Sánchez G, Paredes G, Oscanoa M, Gerónimo J, Miranda RN, Castillo JJ.
Am J Hematol. 2014 Sep 5. doi: 10.1002/ajh.23843. [Epub ahead of print] No abstract available.
PMID: 25196949 [PubMed - as supplied by publisher]
Related citations
Select item 25196947 57. mRNA-based dendritic cell vaccines.
Benteyn D, Heirman C, Bonehill A, Thielemans K, Breckpot K.
20
Expert Rev Vaccines. 2014 Sep 8:1-16. [Epub ahead of print]
PMID: 25196947 [PubMed - as supplied by publisher]
Related citations
Select item 25196525 58.
Recent Approaches in Vaccine Development against Streptococcus pneumoniae.
Tarahomjoo S.
J Mol Microbiol Biotechnol. 2014 Aug 30;24(4):215-227. [Epub ahead of print]
PMID: 25196525 [PubMed - as supplied by publisher]
Related citations
Select item 25196483 59.
Mechanisms of HIV Protein Degradation into Epitopes: Implications for Vaccine Design.
Rucevic M, Boucau J, Dinter J, Kourjian G, Le Gall S.
Viruses. 2014 Aug 21;6(8):3271-3292. Review.
PMID: 25196483 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 25196393 60.
Vaccination of koalas (Phascolarctos cinereus) with a recombinant chlamydial major outer membrane protein adjuvanted with poly I:C, a host defense peptide and polyphosphazine, elicits strong and long lasting cellular and humoral immune responses.
Khan SA, Waugh C, Rawlinson G, Brumm J, Nilsson K, Gerdts V, Potter A, Polkinghorne A, Beagley K, Timms P.
Vaccine. 2014 Sep 4. pii: S0264-410X(14)01160-8. doi: 10.1016/j.vaccine.2014.08.037. [Epub ahead of print]
21
PMID: 25196393 [PubMed - as supplied by publisher]
Related citations
Select item 25196381 61.
Options and Obstacles for Designing a Universal Influenza Vaccine.
Jang YH, Seong BL.
Viruses. 2014 Aug 18;6(8):3159-3180. Review.
PMID: 25196381 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 25196380 62.
Challenges in Mucosal HIV Vaccine Development: Lessons from Non-Human Primate Models.
Tuero I, Robert-Guroff M.
Viruses. 2014 Aug 15;6(8):3129-3158. Review.
PMID: 25196380 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 25196370 63.
Genome-based vaccine design: the promise for malaria and other infectious diseases.
Doolan DL, Apte SH, Proietti C.
Int J Parasitol. 2014 Sep 4. pii: S0020-7519(14)00194-5. doi: 10.1016/j.ijpara.2014.07.010. [Epub ahead of print] Review.
PMID: 25196370 [PubMed - as supplied by publisher]
Related citations
22
Select item 25195604 64.
Factors influencing adolescent girls' decision in initiation for human papillomavirus vaccination: a cross-sectional study in Hong Kong.
Lee A, Ho M, Cheung CK, Keung VM.
BMC Public Health. 2014 Sep 8;14(1):925. [Epub ahead of print]
PMID: 25195604 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 25195512 65.
Costimulatory molecules as vaccine adjuvants: to 4-1BB or not to 4-1BB?
Rahman K, Iyer SS.
Cell Mol Immunol. 2014 Sep 8. doi: 10.1038/cmi.2014.90. [Epub ahead of print] No abstract available.
PMID: 25195512 [PubMed - as supplied by publisher]
Related citations
Select item 25195511 66.
Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44+CD62Lhigh IL-7R+ CTLs with up- and downregulation of anti- and pro-apoptosis genes.
Wang R, Freywald A, Chen Y, Xu J, Tan X, Xiang J.
Cell Mol Immunol. 2014 Sep 8. doi: 10.1038/cmi.2014.72. [Epub ahead of print]
PMID: 25195511 [PubMed - as supplied by publisher]
Related citations
Select item 25195143 67.
23
Influenza virus hemagglutinin as a vaccine antigen produced in bacteria.
Sączyńska V.
Acta Biochim Pol. 2014 Sep 8. [Epub ahead of print]
PMID: 25195143 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 25195141 68.
Vaccination against influenza in pregnant women.
Brydak LB, Nitsch-Osuch A.
Acta Biochim Pol. 2014 Sep 8. [Epub ahead of print]
PMID: 25195141 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 25194998 69.
A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei.
Gregory AE, Judy BM, Qazi O, Blumentritt BSc CA, Brown KA, Shaw AM, Torres AG, Titball RW.
Nanomedicine. 2014 Sep 3. pii: S1549-9634(14)00428-6. doi: 10.1016/j.nano.2014.08.005. [Epub ahead of print]
PMID: 25194998 [PubMed - as supplied by publisher]
Related citations
Select item 25194571 70.
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge.
Stanley DA, Honko AN, Asiedu C, Trefry JC, Lau-Kilby AW, Johnson JC, Hensley L, Ammendola V, Abbate A, Grazioli F, Foulds KE, Cheng C, Wang L, Donaldson MM,
24
Colloca S, Folgori A, Roederer M, Nabel GJ, Mascola J, Nicosia A, Cortese R, Koup RA, Sullivan NJ.
Nat Med. 2014 Sep 7. doi: 10.1038/nm.3702. [Epub ahead of print]
PMID: 25194571 [PubMed - as supplied by publisher]
Related citations
Select item 25193980 71.
Emergency Settings: Be Prepared to Vaccinate Persons Aged 15 and Over Against Measles.
Kaiser R.
J Infect Dis. 2014 Sep 5. pii: jiu463. [Epub ahead of print] No abstract available.
PMID: 25193980 [PubMed - as supplied by publisher]
Related citations
Select item 25193978 72.
Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria.
Ferrari MJ, Fermon F, Nackers F, Llosa A, Magone C, Grais RF.
Int Health. 2014 Sep 5. pii: ihu062. [Epub ahead of print]
PMID: 25193978 [PubMed - as supplied by publisher]
Related citations
Select item 25193634 73.
B Cell Responses to Influenza Infection and Vaccination.
Chiu C, Ellebedy AH, Wrammert J, Ahmed R.
Curr Top Microbiol Immunol. 2014 Sep 6. [Epub ahead of print]
PMID: 25193634
25
[PubMed - as supplied by publisher]
Related citations
Select item 25193462 74.
Combination of vaccine-strain measles and mumps virus synergistically kills a wide range of human hematological cancer cells: Special focus on acute myeloid leukemia.
Zhang LF, Tan DQ, Jeyasekharan AD, Hsieh WS, Ho AS, Ichiyama K, Ye M, Pang B, Ohba K, Liu X, de Mel S, Cuong BK, Chng WJ, Ryo A, Suzuki Y, Yeoh KG, Toan NL, Yamamoto N.
Cancer Lett. 2014 Sep 1. pii: S0304-3835(14)00474-1. doi: 10.1016/j.canlet.2014.08.034. [Epub ahead of print]
PMID: 25193462 [PubMed - as supplied by publisher]
Related citations
Select item 25193323 75.
In vitro stimulation with HBV therapeutic vaccine candidate Nasvac activates B and T cells from chronic hepatitis B patients and healthy donors.
Lobaina Y, Hardtke S, Wedemeyer H, Aguilar JC, Schlaphoff V.
Mol Immunol. 2014 Sep 2. pii: S0161-5890(14)00197-7. doi: 10.1016/j.molimm.2014.08.003. [Epub ahead of print]
PMID: 25193323 [PubMed - as supplied by publisher]
Related citations
Select item 25193104 76.
Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases.
Terry FE, Moise L, Martin RF, Torres M, Pilotte N, Williams SA, De Groot AS.
Expert Rev Vaccines. 2014 Sep 5:1-15. [Epub ahead of print]
PMID: 25193104 [PubMed - as supplied by publisher]
26
Related citations
Select item 25192975 77.
Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice.
Kim E, Okada K, Kenniston T, Raj VS, AlHajri MM, Farag EA, AlHajri F, Osterhaus AD, Haagmans BL, Gambotto A.
Vaccine. 2014 Sep 3. pii: S0264-410X(14)01199-2. doi: 10.1016/j.vaccine.2014.08.058. [Epub ahead of print]
PMID: 25192975 [PubMed - as supplied by publisher]
Related citations
Select item 25192974 78.
Impact of conjugation chemistry on the immunogenicity of S. Typhimurium conjugate vaccines.
Stefanetti G, Rondini S, Lanzilao L, Saul A, MacLennan CA, Micoli F.
Vaccine. 2014 Sep 2. pii: S0264-410X(14)01194-3. doi: 10.1016/j.vaccine.2014.08.056. [Epub ahead of print]
PMID: 25192974 [PubMed - as supplied by publisher]
Related citations
Select item 25192973 79.
Risk groups for yellow fever vaccine-associated viscerotropic disease (YEL-AVD).
Seligman SJ.
Vaccine. 2014 Sep 3. pii: S0264-410X(14)01174-8. doi: 10.1016/j.vaccine.2014.08.051. [Epub ahead of print] Review.
PMID: 25192973 [PubMed - as supplied by publisher]
Related citations
27
Select item 25192808 80.
Efficacy of a formalin-inactivated vaccine against Streptococcus iniae infection in the farmed grouper Epinephelus coioides by intraperitoneal immunization.
Huang HY, Chen YC, Wang PC, Tsai MA, Yeh SC, Liang HJ, Chen SC.
Vaccine. 2014 Sep 1. pii: S0264-410X(14)01162-1. doi: 10.1016/j.vaccine.2014.08.039. [Epub ahead of print]
PMID: 25192808 [PubMed - as supplied by publisher]
Related citations
Select item 25192807 81.
Qualitative evaluation of Rhode Island's healthcare worker influenza vaccination regulations.
Lindley MC, Dube D, Kalayil EJ, Kim H, Paiva K, Raymond P.
Vaccine. 2014 Sep 1. pii: S0264-410X(14)01176-1. doi: 10.1016/j.vaccine.2014.08.052. [Epub ahead of print]
PMID: 25192807 [PubMed - as supplied by publisher]
Related citations
Select item 25192686 82.
10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D-Conjugate Vaccine: A Review in Infants and Children.
Plosker GL.
Paediatr Drugs. 2014 Sep 6. [Epub ahead of print]
PMID: 25192686 [PubMed - as supplied by publisher]
Related citations
Select item 25191902 83.
Ninth World Congress on Vaccines, Immunisation and Immunotherapy.
28
Kurstak E.
Hum Vaccin Immunother. 2014 Sep 5;11(1). [Epub ahead of print] No abstract available.
PMID: 25191902 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 25191323 84.
Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans.
Toapanta FR, Simon JK, Barry EM, Pasetti MF, Levine MM, Kotloff KL, Sztein MB.
Front Immunol. 2014 Aug 20;5:374. doi: 10.3389/fimmu.2014.00374. eCollection 2014.
PMID: 25191323 [PubMed] Free PMC Article
Related citations
Select item 25190737 85.
Survey of the bp/tee genes from clinical Group A Streptococcus isolates in New Zealand - implications for vaccine development.
Steemson JD, Moreland NJ, Williamson D, Morgan J, Carter PE, Proft T.
J Med Microbiol. 2014 Sep 4. pii: jmm.0.080804-0. doi: 10.1099/jmm.0.080804-0. [Epub ahead of print]
PMID: 25190737 [PubMed - as supplied by publisher]
Related citations
Select item 25190531 86.
Comment on 'Herpes zoster ophthalmicus reduction: implementation of shingles vaccination in the UK'
Clearkin L. 29
Eye (Lond). 2014 Sep 5. doi: 10.1038/eye.2014.204. [Epub ahead of print] No abstract available.
PMID: 25190531 [PubMed - as supplied by publisher]
Related citations
Select item 25190325 87.
An enhanced immune response against G250, induced by a heterologous DNA prime-protein boost vaccination, using polyethyleneimine as a DNA vaccine adjuvant.
Sun Z, Liu B, Ruan X, Liu Q.
Mol Med Rep. 2014 Sep 4. doi: 10.3892/mmr.2014.2537. [Epub ahead of print]
PMID: 25190325 [PubMed - as supplied by publisher]
Related citations
Select item 25190285 88.
Dendritic cell-targeted vaccines - hope or hype?
Kastenmüller W, Kastenmüller K, Kurts C, Seder RA.
Nat Rev Immunol. 2014 Sep 5. doi: 10.1038/nri3727. [Epub ahead of print]
PMID: 25190285 [PubMed - as supplied by publisher]
Related citations
Select item 25189358 89.
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04- adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.
Skinner SR, Szarewski A, Romanowski B, Garland SM, Lazcano-Ponce E, Salmerón J, Del Rosario-Raymundo MR, Verheijen RH, Quek SC, da Silva DP, Kitchener H, Fong KL, Bouchard C, Money DM, Ilancheran A, Cruickshank ME, Levin MJ, Chatterjee A, Stapleton JT, Martens M, Quint W, David MP, Meric D, Hardt K, Descamps D, Geeraerts B, Struyf F, Dubin G; for the VIVIANE Study Group.
Lancet. 2014 Sep 1. pii: S0140-6736(14)60920-X. doi: 10.1016/S0140- 6736(14)60920-X. [Epub ahead of print] 30
PMID: 25189358 [PubMed - as supplied by publisher]
Related citations
Select item 25189357 90.
HPV vaccination: for women of all ages?
Castle PE, Schmeler KM.
Lancet. 2014 Sep 1. pii: S0140-6736(14)61230-7. doi: 10.1016/S0140- 6736(14)61230-7. [Epub ahead of print] No abstract available.
PMID: 25189357 [PubMed - as supplied by publisher]
Related citations
Select item 25189087 91.
Cost-effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK.
Jiang Y, Gauthier A, Keeping S, Carroll S.
Expert Rev Pharmacoecon Outcomes Res. 2014 Sep 5:1-15. [Epub ahead of print]
PMID: 25189087 [PubMed - as supplied by publisher]
Related citations
Select item 25188934 92.
[Comparison between the vaccine and the standard reference strains of Brucella].
Wang N, Xiao P, Tian G, Jiang H, Piao D, Zhao H, Sun Y.
Zhonghua Liu Xing Bing Xue Za Zhi. 2014 May;35(5):613-4. Chinese. No abstract available.
PMID: 25188934 [PubMed - in process]
Related citations
31
AMEDEO - Vaccines Publicaciones (08 - 09 - 2014): 31 artículos nuevos.
Vacunas BCG – ONCO BCG (Mycobacterium bovis)
19. SOH SB, Han PY, Tam KT, Yung CF, et al. Investigations into an outbreak of suppurative lymphadenitis with BCG vaccine SSI in Singapore. Vaccine. 2014 Aug 27. pii: S0264-410X(14)01155. PubMed: www.amedeo.com/p2.php?id=25173482&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25173482
Vacunas neumococo (Streptococcus pneumoniae)
29. KOTHARI N, Genschmer KR, Kothari S, Kim JA, et al. Preparation and testing of a Vi conjugate vaccine using pneumococcal surface protein A (PspA) from Streptococcus pneumoniae as the carrier protein. Vaccine. 2014 Aug 27. pii: S0264-410X(14)01164. PubMed: www.amedeo.com/p2.php?id=25171842&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25171842
Vacuna tosferina (Bordetella pertussis)
1. SHAPIRO ED. Preventing pertussis. BMJ. 2014;349:g4518. PubMed: www.amedeo.com/p2.php?id=25035398&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/25035398
Vacunas, otras
1. SHAPIRO ED. Preventing pertussis. BMJ. 2014;349:g4518. PubMed: www.amedeo.com/p2.php?id=25035398&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/25035398
2. RAUCH S, Gough P, Kim HK, Schneewind O, et al. Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection. Infect Immun. 2014 Sep 2. pii: IAI.02328. PubMed: www.amedeo.com/p2.php?id=25183728&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25183728
3. HE B, Chang H, Liu Z, Huang C, et al. Infection of influenza virus NA vaccinated mice with homologous influenza virus leads to strong protection against heterologous influenza viruses. J Gen Virol. 2014 Aug 28. pii: vir.0.067736-0. doi: 10.1099/vir.0.067736. PubMed: www.amedeo.com/p2.php?id=25170051&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25170051
4. HERATI RS, Reuter MA, Dolfi DV, Mansfield KD, et al. Circulating CXCR5+PD-1+ Response Predicts Influenza Vaccine Antibody Responses in
32
Young Adults but not Elderly Adults. J Immunol. 2014 Aug 29. pii: 1302503. PubMed: www.amedeo.com/p2.php?id=25172499&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25172499
5. FOUDA GG, Cunningham CK, McFarland EJ, Borkowsky W, et al. Infant HIV-1 gp120 vaccination elicits robust and durable anti-V1V2 IgG responses and only rare Envelope-specific IgA responses. J Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=25170104&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25170104
6. GRAY GE, Corey L. Reevaluating HIV Vaccine Clinical Trials Policy for Infants. J Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=25170103&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/25170103
7. SKINNER SR, Szarewski A, Romanowski B, Garland SM, et al. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study. Lancet. 2014 Sep 1. pii: S0140-6736(14)60920. PubMed: www.amedeo.com/p2.php?id=25189358&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25189358
8. CASTLE PE, Schmeler KM. HPV vaccination: for women of all ages? Lancet. 2014 Sep 1. pii: S0140-6736(14)61230. PubMed: www.amedeo.com/p2.php?id=25189357&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/25189357
9. MULLARD A. Experimental Ebola drugs enter the limelight. Lancet. 2014;384:649. PubMed: www.amedeo.com/p2.php?id=25157386&s=vac&pm=badc2a9eebb0fad
Share: http://m.amedeo.com/25157386
10. HABER P, Schembri CP, Lewis P, Hibbs B, et al. Notes from the field: reports of expired live attenuated influenza vaccine being administered - United States, 2007-2014. MMWR Morb Mortal Wkly Rep. 2014;63:773. PubMed: www.amedeo.com/p2.php?id=25188496&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25188496
11. MADHI SA, Cutland CL, Kuwanda L, Weinberg A, et al. Influenza vaccination of pregnant women and protection of their infants.
33
N Engl J Med. 2014;371:918-31. PubMed: www.amedeo.com/p2.php?id=25184864&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25184864
12. LEDERER SE. The challenges of challenge experiments. N Engl J Med. 2014;371:695-7. PubMed: www.amedeo.com/p2.php?id=25140955&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/25140955
13. WALTER EB, Kemper AR, Dolor RJ, Dunne EF, et al. Pain in Adolescent Girls Receiving HPV Vaccine with Concomitantly Administered Vaccines: Pediatr Infect Dis J. 2014. PubMed: www.amedeo.com/p2.php?id=25170553&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25170553
14. GAHR P, DeVries AS, Wallace G, Miller C, et al. An outbreak of measles in an undervaccinated community. Pediatrics. 2014;134:e220-8. PubMed: www.amedeo.com/p2.php?id=24913790&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24913790
15. STARAS SA, Vadaparamil ST, Patel RP, Shenkman EA, et al. Parent perceptions important for HPV vaccine initiation among low income adolescent girls. Vaccine. 2014 Aug 30. pii: S0264-410X(14)01178. PubMed: www.amedeo.com/p2.php?id=25180815&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25180815
16. RUIZ JB, Bell RA. Understanding vaccination resistance: Vaccine search term selection bias and the valence of retrieved information. Vaccine. 2014 Aug 28. pii: S0264-410X(14)01165. PubMed: www.amedeo.com/p2.php?id=25176640&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25176640
17. NJUGUNA IN, Ambler G, Reilly M, Ondondo B, et al. PedVacc 002: A phase 1 randomized clinical trial of MVA.HIVA vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in Nairobi. Vaccine. 2014 Aug 27. pii: S0264-410X(14)01157. PubMed: www.amedeo.com/p2.php?id=25173484&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25173484
18. ATSMON J, Caraco Y, Ziv-Sefer S, Shaikevich D, et al.
34
Priming by a novel universal influenza vaccine (Multimeric-001)-A gateway for improving immune response in the elderly population. Vaccine. 2014 Aug 27. pii: S0264-410X(14)01154. PubMed: www.amedeo.com/p2.php?id=25173483&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25173483
19. SOH SB, Han PY, Tam KT, Yung CF, et al. Investigations into an outbreak of suppurative lymphadenitis with BCG vaccine SSI in Singapore. Vaccine. 2014 Aug 27. pii: S0264-410X(14)01155. PubMed: www.amedeo.com/p2.php?id=25173482&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25173482
20. ANN J, Samant M, Rheaume C, Dumas C, et al. Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines. Vaccine. 2014 Aug 27. pii: S0264-410X(14)01152. PubMed: www.amedeo.com/p2.php?id=25173481&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25173481
21. LEE JS, Kwon YM, Hwang HS, Lee YN, et al. Baculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virus. Vaccine. 2014 Aug 27. pii: S0264-410X(14)01168. PubMed: www.amedeo.com/p2.php?id=25173478&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25173478
22. WANG Y, Dong D, Cheng G, Zuo S, et al. Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in China. Vaccine. 2014 Aug 27. pii: S0264-410X(14)01092. PubMed: www.amedeo.com/p2.php?id=25173477&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25173477
23. NEWMAN PA, Chakrapani V, Weaver J, Shunmugam M, et al. Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India. Vaccine. 2014 Aug 27. pii: S0264-410X(14)01166. PubMed: www.amedeo.com/p2.php?id=25173475&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25173475
24. WONG G, Audet J, Fernando L, Fausther-Bovendo H, et al. Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents. Vaccine. 2014 Aug 27. pii: S0264-410X(14)01151.
35
PubMed: www.amedeo.com/p2.php?id=25173474&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25173474
25. TEETER BS, Garza KB, Stevenson TL, Williamson MA, et al. Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies. Vaccine. 2014 Aug 26. pii: S0264-410X(14)01163. PubMed: www.amedeo.com/p2.php?id=25171848&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25171848
26. BARI FD, Parida S, Tekleghiorghis T, Dekker A, et al. Genetic and antigenic characterisation of serotype A FMD viruses from East Africa to select new vaccine strains. Vaccine. 2014 Aug 26. pii: S0264-410X(14)01156. PubMed: www.amedeo.com/p2.php?id=25171846&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25171846
27. VALENZISE M, Cascio A, Wasniewska M, Zirilli G, et al. Post vaccine acute disseminated encephalomyelitis as the first manifestation of chromosome 22q11.2 deletion syndrome in a 15-month old baby: A case report. Vaccine. 2014 Aug 30. pii: S0264-410X(14)01170. PubMed: www.amedeo.com/p2.php?id=25171844&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25171844
28. SIMONELLA L, Canfell K. Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countries. Vaccine. 2014 Aug 26. pii: S0264-410X(14)01171. PubMed: www.amedeo.com/p2.php?id=25171843&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25171843
29. KOTHARI N, Genschmer KR, Kothari S, Kim JA, et al. Preparation and testing of a Vi conjugate vaccine using pneumococcal surface protein A (PspA) from Streptococcus pneumoniae as the carrier protein. Vaccine. 2014 Aug 27. pii: S0264-410X(14)01164. PubMed: www.amedeo.com/p2.php?id=25171842&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25171842
30. LI T, Lin H, Zhang Y, Li M, et al. Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles. Vaccine. 2014;32:1921-31. PubMed: www.amedeo.com/p2.php?id=24530406&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24530406
36
31. WILSON JR, Tzeng WP, Spesock A, Music N, et al. Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin. Virology. 2014;458-459C:114-124. PubMed: www.amedeo.com/p2.php?id=24928044&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24928044
PATENTES
United States Patent and Trademark Office (USPTO)
Estrategia de búsqueda “vaccine” en título y abstract
(ABST/vaccine AND ISD/20140902->20140912): 10 patentes recuperadas.
Vacunas neumococo (Streptococcus pneumoniae)
2 8,828,409 Vaccine comprising recombinant CLPP protein of Streptococcus pneumoniae
Vacunas, otras
PAT. NO. Title
1 8,828,687 Method for the production of recombinant virus, DNA constructs,
recombinant virus and vaccine compositions
2 8,828,409 Vaccine comprising recombinant CLPP protein of Streptococcus
pneumoniae
3 8,828,402 Augmentation of titer for vaccination in animals
4 8,822,192 Human rotavirus vaccine strains and diagnostics
5 8,821,895 Streptococcus pyogenes antigens and corresponding DNA
fragments
6 8,821,892 Yeast-based therapeutic for chronic hepatitis C infection
7 8,821,890 Influenza virus vaccine composition and methods of use
8 8,821,886 Recombinant antigen
9 8,821,882 Vaccine preparation for neospora caninum infection
10 8,821,852 Vaccines with live bacterial isolates for systemic administration
37
European Patent Office (EPO)
Acumulado entre el 2 y el 12 de septiembre de 2014: 27 patentes recuperadas
Vacunas neumococo (Streptococcus pneumoniae)
14. SYNTHETIC STREPTOCOCCUS PNEUMONIAE VACCINE
Publication info: US2014248303 (A1) 2014-09-04
Vacuna tuberculosis (Mycobacterium tuberculosis)
24. PLASTID-EXPRESSED MYCOBACTERIUM TUBERCULOSIS VACCINE ANTIGENS ESAT-6 AND MTB72F FUSED TO CHOLERA TOXIN B SUBUNIT
Vacunas, otras
1. AN INFECTIOUS RECOMBINANT CLONING SYSTEM OF DUCK ENTERITIS VIRUS VACCINE STRAIN, CONSTRUCTION METHOD AND USE THEREOF
HK1162599 (A1) 2014-09-05 Publication info:
2. METHODS AND COMPOSITIONS FOR ENHANCING AN IMMUNE RESPONSE, BLOCKING MONOCYTE MIGRATION, AMPLIFYING VACCINE IMMUNITY AND INHIBITING TUMOR GROWTH AND METASTASIS
WO2014134621 (A2) 2014-09-04 Publication info:
3. VACCINE BASED ON STAPHYLOCOCCAL SUPERANTIGEN-LIKE 3 PROTEIN (SSL3)
US2014248273 (A1) 2014-09-04 Publication info:
4. CROSS-PROTECTIVE ARENAVIRUS VACCINES AND THEIR METHOD OF USE
US2014249467 (A1) 2014-09-04 Publication info:
5. QUANTIFICATION OF VACCINE COMPOSITIONS
US2014248603 (A1) 2014-09-04 Publication info:
6. NANOPARTICLE TUMOUR VACCINES
US2014248360 (A1) 2014-09-04 Publication info:
7. CONTROLLED RELEASE VACCINES AND METHODS FOR TREATING BRUCELLA DISEASES AND DISORDERS
38
US2014248354 (A1) 2014-09-04 Publication info:
8. Liposomal Vaccine Compositions Comprising a Polysaccharide Antigen and a Protein Adjuvant
US2014248337 (A1) 2014-09-04 Publication info:
9. ADJUVANTED INFLUENZA B VIRUS VACCINES FOR PEDIATRIC PRIMING
US2014248320 (A1) 2014-09-04 Publication info:
10. METHODS AND COMPOSITIONS FOR ENHANCING AN IMMUNE RESPONSE, BLOCKING MONOCYTE MIGRATION, AMPLIFYING VACCINE IMMUNITY AND INHIBITING TUMOR GROWTH AND METASTASIS
US2014248315 (A1) 2014-09-04 Publication info:
11. INFLUENZA VACCINES INCLUDING COMBINATIONS OF PARTICULATE ADJUVANTS AND IMMUNOPOTENTIATORS
US2014248312 (A1) 2014-09-04 Publication info:
12. CATIONIC METAL OXIDES FOR USE AS VACCINE ADJUVANTS
US2014248310 (A1) 2014-09-04 Publication info:
13. DNA PROMOTERS AND ANTHRAX VACCINES
US2014248309 (A1) 2014-09-04 Publication info:
14. SYNTHETIC STREPTOCOCCUS PNEUMONIAE VACCINE
US2014248303 (A1) 2014-09-04 Publication info:
15. PEPTIDE VACCINES FOR CANCERS EXPRESSING TUMOR-ASSOCIATED ANTIGENS
US2014248300 (A1) 2014-09-04 Publication info:
16. RECOMBINANT PROTEINS FOR USE IN VACCINE, ANTIBODIES AGAINST SAID PROTEINS, AND DIAGNOSTIC AND THERAPEUTIC METHODS INCLUDING THE SAME
US2014248272 (A1) 2014-09-04 Publication info:
17. Equine Rhinitis vaccine
39
EP2772266 (A1) 2014-09-03 Publication info:
18. VACCINE AGAINST BOVINE LEUKEMIA VIRUS
WO2014131844 (A1) 2014-09-04 Publication info:
19. VACCINES DIRECTED AGAINST HUMAN ENTEROVIRUSES
EP2773372 (A2) 2014-09-10 Publication info:
20. PROTECTIVE VACCINE BASED ON STAPHYLOCOCCUS AUREUS SA2074 PROTEIN
EP2773655 (A1) 2014-09-10 Publication info:
21. PROTECTIVE VACCINE BASED ON STAPHYLOCOCCUS AUREUS SA2451 PROTEIN
EP2773370 (A2) 2014-09-10 Publication info:
22. TOPK PEPTIDES AND VACCINES INCLUDING THE SAME
EP2771350 (A1) 2014-09-03 Publication info:
23. DIATOM-BASED VACCINES
EP2771453 (A1) 2014-09-03 Publication info:
24. PLASTID-EXPRESSED MYCOBACTERIUM TUBERCULOSIS VACCINE ANTIGENS ESAT-6 AND MTB72F FUSED TO CHOLERA TOXIN B SUBUNIT
EP2771469 (A1) 2014-09-03 Publication info:
25. VACCINES AND METHODS FOR CREATING A VACCINE FOR INDUCING IMMUNITY TO ALL DENGUE VIRUS SEROTYPES
EP2771366 (A1) 2014-09-03 Publication info:
26. IMPROVED HCV VACCINES AND METHODS FOR USING THE SAME
EP2771035 (A1) 2014-09-03 Publication info:
27. VACCINE
40
EP2771352 (A1) 2014-09-03 Publication info:
41